<DOC>
	<DOCNO>NCT00576940</DOCNO>
	<brief_summary>The aim study assess clinical effect immunomodulating enteral nutrition patient undergoing resection gastrointestinal cancer . 196 subject randomly assign two study group : standard immunostimulating . The study fail demonstrate clear advantage routine postoperative immunonutrition patient undergo elective upper gastrointestinal surgery</brief_summary>
	<brief_title>Standard Immunostimulating Enteral Nutrition Surgical Patients</brief_title>
	<detailed_description>Background &amp; Aim : The administration immunomodulating enteral diet postoperative period patient major gastrointestinal surgery intend reduce number postoperative complication shorten hospital stay . The aim study assess clinical effect enteral immunostimulatory nutrition surgical patient . Material Methods : 196 patient undergoing resection pancreatic gastric cancer randomize double-blind manner receive early postoperative enteral nutrition immunostimulating diet ( IMEN group : formula supplement arginine , glutamine , omega-3 fatty acid ) oligopeptic control ( SEN group ) June 2004 September 2007 . Enteral nutrition start 6 hour surgery continue 7 day , target volume 100 ml/h . All malnourish patient require preoperative nutritional therapy exclude study treat preoperatively . Outcome measure : number type complication , length hospital stay , mortality , treatment tolerance , liver kidney function . Results : One hundred eighty-three patient ( 91 SEN , 92 IMEN group , 69 F , 114 M , mean age 61.2 ) 196 initially enrol analyze . There 2 death group . Median postoperative hospital stay 12.4 day ( SD 5.9 ) SEN group 12.9 day ( SD 8.0 ) IMEN group ( p=0.42 ) . Complications observe 21 patient ( 23.1 % ) SEN 23 ( 25.2 % ) IMEN group ( p &gt; 0.05 ) . 4 ( 4.4 % ) patient SEN group 4 ( 4.4 % ) IMEN surgical complication ( p &gt; 0.05 ) . There differences liver kidney function , visceral protein concentration treatment tolerance . Conclusion : Clinical laboratory parameter show benefit immunomodulating enteral nutrition standard enteral nutrition patient major gastrointestinal surgery far complication , hospital stay , mortality treatment tolerance safety consider .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Adults age 1880 year undergo subtotal total gastric resection lymphadenectomy pancreatoduodenectomy/ total pancreatectomy lymphadenectomy , good general status ( Karnofsky &gt; 80 , Eastern Cooperative Oncology Group ( ECOG ) grade 0 1 ) ; confirm neoplastic dissemination distant metastases No severe concomitant disease ( heart failure , chronic obstructive pulmonary disease [ COPD ] , coronary aortic bypass graft [ CABG ] , etc . ) No history know allergy drug intolerance Patients metastatic unresectable disease Pregnant In poor general status ( Karnofsky &lt; 80 , Eastern Cooperative Oncology Group ( ECOG ) &gt; 1 ) With recent history severe heart , lung , kidney liver failure With history allergy drug intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>enteral nutrition , immunomodulating nutrition</keyword>
</DOC>